Amgen Adds USD 300 Million to US Manufacturing, Total Nears USD 2 Billion
Amgen invests an additional USD 300 Million in US manufacturing, bringing total investment to nearly USD 2 Billion to strengthen supply chain resilience, and next-generation technology.
Pharmaceutical Supply Chain Resilience | 06/05/2026 | By News Bureau
WHO Scales Biomanufacturing Workforce Network to Advance Equitable Access
The World Health Organization (WHO) has expanded its global biomanufacturing workforce network under the 2023 training initiative, following a rigorous selection process to strengthen equitable access to medicines and global health security.
Pharmaceutical Supply Chain Resilience | 02/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy